These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 15750632

  • 1. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
    Stein U, Bergmann S, Scheffer GL, Scheper RJ, Royer HD, Schlag PM, Walther W.
    Oncogene; 2005 May 19; 24(22):3606-18. PubMed ID: 15750632
    [Abstract] [Full Text] [Related]

  • 2. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
    Lange C, Walther W, Schwabe H, Stein U.
    Biochem Biophys Res Commun; 2000 Nov 11; 278(1):125-33. PubMed ID: 11071864
    [Abstract] [Full Text] [Related]

  • 3. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
    van Zon A, Mossink MH, Schoester M, Scheper RJ, Sonneveld P, Wiemer EA.
    Cancer Res; 2004 Jul 15; 64(14):4887-92. PubMed ID: 15256459
    [Abstract] [Full Text] [Related]

  • 4. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B, Liu J, Liu B, Dong Y, Liu J, Song Y, Sun Z.
    J Cell Physiol; 2011 Dec 15; 226(12):3433-41. PubMed ID: 21344396
    [Abstract] [Full Text] [Related]

  • 5. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
    Mossink MH, van Zon A, Fränzel-Luiten E, Schoester M, Kickhoefer VA, Scheffer GL, Scheper RJ, Sonneveld P, Wiemer EA.
    Cancer Res; 2002 Dec 15; 62(24):7298-304. PubMed ID: 12499273
    [Abstract] [Full Text] [Related]

  • 6. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
    Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M, Kuwano M, Kohno K.
    Cancer Res; 1996 Sep 15; 56(18):4224-8. PubMed ID: 8797596
    [Abstract] [Full Text] [Related]

  • 7. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
    Steiner E, Holzmann K, Pirker C, Elbling L, Micksche M, Sutterlüty H, Berger W.
    J Cell Sci; 2006 Feb 01; 119(Pt 3):459-69. PubMed ID: 16418217
    [Abstract] [Full Text] [Related]

  • 8. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.
    Labialle S, Dayan G, Gayet L, Rigal D, Gambrelle J, Baggetto LG.
    Nucleic Acids Res; 2004 Feb 01; 32(13):3864-76. PubMed ID: 15272088
    [Abstract] [Full Text] [Related]

  • 9. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
    Obama K, Kanai M, Kawai Y, Fukushima M, Takabayashi A.
    Int J Oncol; 2002 Aug 01; 21(2):309-14. PubMed ID: 12118326
    [Abstract] [Full Text] [Related]

  • 10. Age associated high level of major vault protein is p53 dependent.
    An HJ, Ryu SJ, Kim SY, Choi HR, Chung JH, Park SC.
    Cell Biochem Funct; 2009 Jul 01; 27(5):289-95. PubMed ID: 19472297
    [Abstract] [Full Text] [Related]

  • 11. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
    Schroeijers AB, Siva AC, Scheffer GL, de Jong MC, Bolick SC, Dukers DF, Slootstra JW, Meloen RH, Wiemer E, Kickhoefer VA, Rome LH, Scheper RJ.
    Cancer Res; 2000 Feb 15; 60(4):1104-10. PubMed ID: 10706131
    [Abstract] [Full Text] [Related]

  • 12. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
    van Vliet EA, Aronica E, Redeker S, Gorter JA.
    Epilepsia; 2004 Dec 15; 45(12):1506-16. PubMed ID: 15571508
    [Abstract] [Full Text] [Related]

  • 13. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T, Ito K, Izumi H, Kimura M, Sano M, Nakagomi H, Maeno K, Hama Y, Shingu K, Tsuchiya S, Kohno K, Fujimori M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [Abstract] [Full Text] [Related]

  • 14. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
    Huffman KE, Corey DR.
    Biochemistry; 2005 Feb 22; 44(7):2253-61. PubMed ID: 15709737
    [Abstract] [Full Text] [Related]

  • 15. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
    Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F.
    Eur J Cancer; 2009 Aug 22; 45(12):2219-27. PubMed ID: 19524433
    [Abstract] [Full Text] [Related]

  • 16. [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell].
    Zhu H, Chen XP, Luo SF, Guan J, Zhang WG, Zhang BX, Wang HP.
    Zhonghua Wai Ke Za Zhi; 2005 Mar 01; 43(5):277-81. PubMed ID: 15842930
    [Abstract] [Full Text] [Related]

  • 17. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
    Silva P, West CM, Slevin N, Valentine H, Ryder WD, Hampson L, Bibi R, Sloan P, Thakker N, Homer J, Hampson I.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):133-40. PubMed ID: 17459603
    [Abstract] [Full Text] [Related]

  • 18. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F, Hou YQ, Song Y, Yuan ZJ.
    Anat Rec (Hoboken); 2013 Jan 01; 296(1):56-63. PubMed ID: 23125179
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil.
    Zhao HY, Ooyama A, Yamamoto M, Ikeda R, Haraguchi M, Tabata S, Furukawa T, Che XF, Zhang S, Oka T, Fukushima M, Nakagawa M, Ono M, Kuwano M, Akiyama S.
    Cancer Res; 2008 Sep 01; 68(17):7035-41. PubMed ID: 18757417
    [Abstract] [Full Text] [Related]

  • 20. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K.
    Cancer Invest; 2008 May 01; 26(4):344-51. PubMed ID: 18443954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.